Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

S3I-201

🥰Excellent
Catalog No. T2505Cas No. 501919-59-1
Alias S3I201, S3I 201

S3I-201 (S3I-201) is a selective Stat3 inhibitor (IC50: 86±33 μM) and low effect towards STAT1/5.

S3I-201

S3I-201

🥰Excellent
Purity: 99.05%
Catalog No. T2505Alias S3I201, S3I 201Cas No. 501919-59-1
S3I-201 (S3I-201) is a selective Stat3 inhibitor (IC50: 86±33 μM) and low effect towards STAT1/5.
Pack SizePriceAvailabilityQuantity
5 mg47 €In Stock
10 mg59 €In Stock
25 mg93 €In Stock
50 mg143 €In Stock
100 mg266 €In Stock
200 mg399 €In Stock
Bulk & Custom
Add to Cart
Questions
TargetMol
View More
Select Batch
Purity:99.05%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
S3I-201 (S3I-201) is a selective Stat3 inhibitor (IC50: 86±33 μM) and low effect towards STAT1/5.
Targets&IC50
STAT3:86 nM (cell free)
In vitro
S3I-201 inhibits Stat3.Stat3 complex formation and Stat3 DNA-binding and transcriptional activities. Furthermore, S3I-201 inhibits growth and induces apoptosis preferentially in tumor cells that contain persistently activated Stat3. Constitutively dimerized and active Stat3C and Stat3 SH2 domain rescue tumor cells from S3I-201-induced apoptosis [1]. Preincubation of CD4 T cells from p53(null)CD45.1 mice with various concentrations of S31-201 suppressed IL-6-induced phosphorylation of STAT3 in a dose-dependent manner as early as 15 min after IL-6 addition. Based on the level of suppression of STAT3 phosphorylation, the IC50 of this inhibitor was determined as 38 μM [2]. Although none of these cell lines was sensitive to S3I-201 (S3I-201) alone, S3I-201 potentiated the antiproliferative effect of cetuximab in all three cell lines (HepG2, SK-HEP1, and Huh-7 cells) [3].
In vivo
Compared with control tumors, which continued to grow, human breast tumors in mice that received S3I-201 displayed strong growth inhibition. Strong inhibition of Stat3 DNA-binding activity in residual tumor tissue from mice treated with S3I-201 compared with control tumor [1]. 8- to 10-wk-old p53nullCD45.1 mice were treated with S31-201 3×/wk at 5 mg/kg, using PBS-treated age-matched p53nullCD45.1 mice as controls. STAT3 phosphorylation in the spleen of S31-201-treated mice was markedly reduced as compared with those treated with PBS [2]. S3I-201 attenuated somatotroph tumor growth and GH secretion in a rat xenograft model [4].
Kinase Assay
Briefly, 100 ml of biotinyl-e-Ac-EPQpYEEIEL-OH (in 50 mM Tris/150 mM NaCl, pH 7.5) was added to each well of streptavidin-coated 96-well microtiter plates and incubated with shaking at 4°C overnight. Then plates were rinsed with PBS/Tween 20 and then two times with 200 ml of BSA-T-PBS (0.2% BSA/0.1% Tween 20/PBS). Then 50 ml of Lck-SH2-GST fusion protein (6.4 ng/ml in BSA-T-PBS) was added to each well of the 96-well plate in the presence and absence of 50 ml of S3I-201 (for 30 and 100 mM final concentrations), and the plate was shaken at room temperature for 4 h. After solutions were removed, each well was rinsed four times with BSA-T-PBS (200 ml), and 100 ml of polyclonal rabbit anti-GST antibody (100 ng/ml in BSA-T-PBS) was added to each well and incubated at 4°C overnight. After washing with BSA-T-PBS, 100 ml of 200 ng/ml BSA-T-PBS horseradish peroxidase-conjugated mouse anti-rabbit antibody was added to each well and incubated for 45 min at room temperature. After four washing steps with BSA-T-PBS and three washing steps with PBS-T, 100 ml of peroxidase substrate was added to each well and incubated for 5-15 min. The peroxidase reaction was stopped by adding 100 ml of 1 M sulfuric acid solution, and absorbance was read at 450 nm with an ELISA plate reader [1].
Cell Research
Proliferating cells were treated with or without S3I-201 for up to 48 h. In some cases, cells were first transfected with Stat3C, ST3-NT, or ST3-SH2 domain or mock-transfected for 24 h before treatment with compound for an additional 24–48 h. Cells were then detached and analyzed by annexin V binding according to the manufacturer's protocol and flow cytometry to quantify the percent apoptosis [1].
Animal Research
Six-week-old female athymic nude mice were purchased from Harlan and maintained in the institutional animal facilities approved by the American Association for Accreditation of Laboratory Animal Care. Athymic nude mice were injected in the left flank area s.c. with 5 × 10^6 human breast cancer MDA-MB-231 cells in 100 μl of PBS. After 5–10 days, tumors with a diameter of 3 mm were established. Animals were given S3I-201 i.v. at 5 mg/kg every 2 or 3 days for 2 weeks and monitored every 2 or 3 days. Animals were stratified so that the mean tumor sizes in all treatment were nearly identical. Tumor volume was calculated according to the formula V = 0.52 × a2× b, where a is the smallest superficial diameter and b is the largest superficial diameter [1].
AliasS3I201, S3I 201
Chemical Properties
Molecular Weight365.36
FormulaC16H15NO7S
Cas No.501919-59-1
SmilesCc1ccc(cc1)S(=O)(=O)OCC(=O)Nc1ccc(C(O)=O)c(O)c1
Relative Density.1.507 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 40 mg/mL (109.48 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7370 mL13.6851 mL27.3703 mL136.8513 mL
5 mM0.5474 mL2.7370 mL5.4741 mL27.3703 mL
10 mM0.2737 mL1.3685 mL2.7370 mL13.6851 mL
20 mM0.1369 mL0.6843 mL1.3685 mL6.8426 mL
50 mM0.0547 mL0.2737 mL0.5474 mL2.7370 mL
100 mM0.0274 mL0.1369 mL0.2737 mL1.3685 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy S3I-201 | purchase S3I-201 | S3I-201 cost | order S3I-201 | S3I-201 chemical structure | S3I-201 in vivo | S3I-201 in vitro | S3I-201 formula | S3I-201 molecular weight